Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
Journal of Clinical Oncology · 10.11.2023 · 41 (32) · 5035-5043
DOI: 10.1200/jco.22.02852 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.11.2023. Verfasst von Gemma G Kenter und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gynaecologic Oncology Amsterdam, Amsterdam University Medical Center, Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The EORTC-55994 trial compared neoadjuvant chemotherapy (NACT) followed by radical surgery with concomitant chemoradiation (CCRT) in patients with Stage IB2-IIB cervical cancer. This trial took almost 12 years to recruit 626 patients with a median follow-up of 8.7 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Gynaecologic Oncology Amsterdam, Amsterdam University Medical Center, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Gynaecologic Oncology, Istituto Nazionale Tumori di Napoli IRCCS "Fondazione G. Pascale", Naples, Italy.
- Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
- Department of Surgical Sciences, AOU Citta della Salute, Gynecologic Oncology, PO SANNA, University of Torino, Torino, Italy.
- Department of Gynecology and Gynecologic Oncology, Medical University of Gdansk, Gdansk, Poland.
- ErasmusMC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
ORCID-Profile: Gemma G Kenter, Ignace Vergote, Heleen van Doorn, Jacobus van der Velden, Nicoletta Colombo, Nelleke Ottevanger
Zitieren
APA
Kenter, G. G., Greggi, S., Vergote, I., Katsaros, D., Kobierski, J., van Doorn, H., Landoni, F., van der Velden, J., Reed, N., Coens, C., van Luijk, I., Colombo, N., Steen-Banasik, E. V., Ottevanger, N., Casado, A., & EORTC-55994 Study Group (2023). Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994. Journal of Clinical Oncology, 41(32), 5035-5043. https://doi.org/10.1200/jco.22.02852
Vancouver
Kenter GG, Greggi S, Vergote I, Katsaros D, Kobierski J, van Doorn H, et al. Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994. Journal of Clinical Oncology. 2023;41(32):5035-5043. doi:10.1200/jco.22.02852
BibTeX
@article{Kenter2023,
author = {Kenter, Gemma G and Greggi, Stefano and Vergote, Ignace and Katsaros, Dionyssios and Kobierski, Juliusz and van Doorn, Heleen and Landoni, Fabio and van der Velden, Jacobus and Reed, Nicholas and Coens, Corneel and van Luijk, Iske and Colombo, Nicoletta and Steen-Banasik, Elzbietta van der and Ottevanger, Nelleke and Casado, Antonio and EORTC-55994 Study Group, EORTC-55994 Study Group},
title = {Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {32},
pages = {5035--5043},
doi = {10.1200/jco.22.02852}
}
EUVIMED